Evolent Health (EVH) PT Lowered to $14 at Truist Securities
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Price: $3.52 --0%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 16
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 16
Join SI Premium – FREE
Truist Securities analyst Jailendra Singh lowered the price target on Evolent Health (NYSE: EVH) to $14.00 (from $15.00) while maintaining a Buy rating.
You May Also Be Interested In
- Damora Therapeutics (DMRA) PT Raised to $60 at Guggenheim
- JPMorgan Assumes Manycore Tech Inc (68:HK) at Neutral
- Akamai Technologies (AKAM) PT Raised to $185 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
